454 Exploring the views of care home staff on the use of antipsychotics for people with dementia amid the COVID-19 pandemic: A qualitative study
Authors: Raza A , Jawad S , Langran T , Donyai P 
Published: April 2023

Introduction

There was an increase in antipsychotic prescribing for people with dementia during the COVID-19 pandemic (1). To explain this increase, the current study was conducted to explore the views of staff working in care homes for the elderly during the pandemic on the use of antipsychotics for residents with Behavioural and Psychological Symptoms of Dementia (BPSD).

Aim

The aim was to explore the use of antipsychotics for people with BPSD during the COVID-19 pandemic by interviewing staff in care homes about their experiences during that time.

Methods

Semi-structured interviews were conducted online with staff working in ten UK elderly care settings using convenience sampling. Participants mainly onsite care home staff were recruited through online networks, for example, Twitter, and support groups such as CHAIN and NIHR clinical research network. Interviews were conducted between May 2021-March 2022, were audio recorded, transcribed verbatim, and analysed inductively using thematic analysis in NVivo version 12.

Results

Ten interviews were completed with managers (n=2), care staff (n=6) and nurses (n=2) in nursing homes (n=7) and residential homes (n=3) (all were female). The first theme ‘Challenges experienced in care provision’ entails challenges experienced in the care environment; residents were confined to their rooms, activities were suspended, staff were absent and stressed, and family visits were barred. The reduced human contact affected residents’ sense of self, mental and physical wellbeing, and in turn, their behaviours. The second theme ‘Prescribing process’ refers to doctors prescribing medicines in response to staff raising concerns. The third theme ‘Attitude toward antipsychotics’ denotes participants’ positive and negative beliefs about antipsychotics. The positive beliefs included antipsychotics being the right choice and beneficial, an increased need and continued use of antipsychotics, use of a combination of medications and weighing the risks and benefits of antipsychotics. The negative beliefs included reports of adverse effects and short-term benefits of antipsychotics, antipsychotics not always beneficial, benefits in deprescribing, dislike for antipsychotics and belief antipsychotics are the last resort. Some expressed the need for antipsychotics had not increased but been driven by health professionals involved.

The fourth theme ‘Other psychotropic medication’ alluded to other commonly used psychotropic medications and associated risks and benefits. The fifth theme ‘Measures implemented within care settings’ represented strategies implemented to avert the initiation or bolster antipsychotic deprescribing such as non-pharmacological approaches, nurses’ assessment of residents before requesting antipsychotics, multidisciplinary consultation, and medication review.

Conclusion

This is the first study that reports care home staff views on antipsychotic use for residents with dementia during the pandemic. The limitations include that only views of female respondents were obtained and the limited sample size. Care homes faced enormous challenges in the provision of care services to residents with dementia during the pandemic. The multitude of difficulties experienced in care homes due to lack of preparedness may have influenced staff to have positive views of antipsychotics and their use as an option during the pandemic. It’s important to acknowledge and address these difficulties for example through education and training interventions to help with future preparedness.

References

1. Howard R, Burns A, Schneider L. Antipsychotic prescribing to people with dementia during COVID-19. The Lancet Neurology. 2020;19(11):892.